June 30, 2025
Condensed Interim Statement of Financial Position
(Unaudited)
| (In thousands of Canadian dollars) |
June 30, 2025 |
March 31, 2025 |
| Assets |
|
|
| Current assets |
|
|
| Cash |
$ 21,740 |
$ 102,215 |
| Trade and other receivables (note 4) |
142,431 |
80,371 |
| Inventories |
17,724 |
18,776 |
| Prepaids |
8,063 |
8,603 |
| Derivative financial assets |
12 |
855 |
|
189,970 |
210,820 |
| Non-current assets |
|
|
| Property and equipment (note 5) |
385,120 |
382,154 |
| Intangible assets (note 6) |
12,290 |
12,879 |
| Right-of-use assets (note 7) |
15,899 |
16,664 |
| Employee benefits asset (note 8) |
73,523 |
64,809 |
| Derivative financial assets |
- |
59 |
|
486,832 |
476,565 |
| Total assets |
$ 676,802 |
$ 687,385 |
| Liabilities and Equity |
|
|
| Current liabilities |
|
|
| Trade and other payables |
$ 167,252 |
$ 182,949 |
| Holdbacks |
35 |
35 |
| Lease liabilities (note 7) |
3,371 |
3,263 |
| Deferred government funding related to operating expenses (note 10) |
25,787 |
27,379 |
| Derivative financial liabilities |
637 |
58 |
|
197,082 |
213,684 |
| Non-current liabilities |
|
|
| Lease liabilities (note 7) |
14,882 |
15,738 |
| Deferred government funding related to capital expenditures (note 10) |
392,089 |
389,690 |
| Employee benefits liability (note 8) |
22,374 |
22,445 |
| Deferred revenue - screening services - other |
4,571 |
4,571 |
|
433,916 |
432,444 |
| Equity |
|
|
| Accumulated surplus |
45,804 |
41,257 |
| Total liabilities and equity |
$ 676,802 |
$ 687,385 |
Contingencies (note 9) and contractual arrangements (note 13)
The accompanying notes are an integral part of these condensed interim financial statements.
Condensed Interim Statement of Comprehensive Income (Loss)
(Unaudited)
| (In thousands of Canadian dollars) |
Three Months Ended June 30 |
|
2025 |
2024 |
| Expenses |
|
|
| Pre-Board Screening |
$ 175,060 |
$ 157,222 |
| Hold Baggage Screening |
46,250 |
40,983 |
| Non-Passenger Screening |
41,103 |
36,855 |
| Restricted Area Identity Card Program |
1,067 |
1,060 |
| Corporate services |
15,032 |
13,519 |
| Total expenses (note 11) |
278,512 |
249,639 |
| Other expenses |
|
|
| Net loss (gain) on fair value of derivative financial instruments |
1,481 |
(147) |
| Finance costs |
169 |
177 |
| Foreign exchange gain |
(219) |
(9) |
| Total other expenses |
1,431 |
21 |
| Financial performance before revenue and government funding |
279,943 |
249,660 |
| Revenue |
|
|
| Finance income |
735 |
902 |
| Miscellaneous income |
18 |
2 |
| Total revenue |
753 |
904 |
| Government funding |
|
|
| Parliamentary appropriations for operating expenses |
259,858 |
234,645 |
| Amortization of deferred government funding related to capital expenditures |
13,008 |
11,041 |
| Parliamentary appropriations for lease payments |
978 |
777 |
| Total government funding (note 10) |
273,844 |
246,463 |
| Financial performance |
$ (5,346) |
$ (2,293) |
| Other comprehensive income |
|
|
| Item that will not be reclassified to financial performance |
|
|
| Remeasurement of defined benefit plans (note 8) |
9,893 |
4,130 |
| Total comprehensive income (loss) |
$ 4,547 |
$ 1,837 |
The accompanying notes are an integral part of these condensed interim financial statements.
Condensed Interim Statement of Changes in Equity
(Unaudited)
For the three months ended June 30:
| (In thousands of Canadian dollars) |
Accumulated surplus |
| Balance, March 31, 2025 |
$ 41,257 |
| Financial performance |
(5,346) |
| Item that will not be reclassified to financial performance |
|
| Remeasurement of defined benefit plans (note 8) |
9,893 |
| Balance, June 30, 2025 |
$ 45,804 |
| Balance, March 31, 2024 |
$ 36,901 |
| Financial performance |
(2,293) |
| Item that will not be reclassified to financial performance |
|
| Remeasurement of defined benefit plans (note 8) |
4,130 |
| Balance, June 30, 2024 |
$ 38,738 |
Condensed Interim Statement of Cash Flows
(Unaudited)
| (In thousands of Canadian dollars) |
Three Months Ended June 30 |
|
2025 |
2024 |
| Cash flows provided by (used in) |
|
|
| Operating activities |
|
|
| Financial performance |
$ (5,346) |
$ (2,293) |
| Items not involving cash |
|
|
| Depreciation and amortization (note 11) |
13,870 |
11,731 |
| Change in fair value of financial instruments at fair value through profit and loss |
1,481 |
(147) |
| Change in net employee benefits asset/liability |
1,108 |
2 |
| Amortization of deferred government funding related to capital expenditures (note 10) |
(13,008) |
(11,041) |
| Net change in working capital balances (note 15) |
(79,549) |
6,513 |
|
(81,444) |
4,765 |
| Investing activities |
|
|
| Parliamentary appropriations received for capital funding (note 10) |
15,022 |
4,223 |
| Purchase of property and equipment |
(13,156) |
(4,199) |
| Purchase of intangible assets |
(74) |
(81) |
|
1,792 |
(57) |
| Financing activities |
|
|
| Lease principal payments |
(823) |
(604) |
|
(823) |
(604) |
| (Decrease) increase in cash |
(80,475) |
4,104 |
| Cash, beginning of period |
102,215 |
9,955 |
| Cash, end of period |
$ 21,740 |
$ 14,059 |
The accompanying notes are an integral part of these condensed interim financial statements.